132 related articles for article (PubMed ID: 35100963)
1. Gamma-Tocotrienol Synergistically Promotes the Anti-proliferative and Pro-apoptotic Effects of Etoposide on Breast Cancer Cell Lines.
Idriss M; Younes M; Abou Najem S; Hodroj MH; Fakhoury R; Rizk S
Curr Mol Pharmacol; 2022; 15(7):980-986. PubMed ID: 35100963
[TBL] [Abstract][Full Text] [Related]
2. Sesamin synergistically potentiates the anticancer effects of γ-tocotrienol in mammary cancer cell lines.
Akl MR; Ayoub NM; Abuasal BS; Kaddoumi A; Sylvester PW
Fitoterapia; 2013 Jan; 84():347-59. PubMed ID: 23266736
[TBL] [Abstract][Full Text] [Related]
3. Beta-Tocotrienol Exhibits More Cytotoxic Effects than Gamma-Tocotrienol on Breast Cancer Cells by Promoting Apoptosis via a P53-Independent PI3-Kinase Dependent Pathway.
Idriss M; Hodroj MH; Fakhoury R; Rizk S
Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32283796
[TBL] [Abstract][Full Text] [Related]
4. γ-Tocotrienol-induced autophagy in malignant mammary cancer cells.
Tiwari RV; Parajuli P; Sylvester PW
Exp Biol Med (Maywood); 2014 Jan; 239(1):33-44. PubMed ID: 24231340
[TBL] [Abstract][Full Text] [Related]
5. Anti-proliferative effects of γ-tocotrienol are associated with suppression of c-Myc expression in mammary tumour cells.
Parajuli P; Tiwari RV; Sylvester PW
Cell Prolif; 2015 Aug; 48(4):421-35. PubMed ID: 26096843
[TBL] [Abstract][Full Text] [Related]
6. Enhanced antiproliferative and apoptotic response to combined treatment of gamma-tocotrienol with erlotinib or gefitinib in mammary tumor cells.
Bachawal SV; Wali VB; Sylvester PW
BMC Cancer; 2010 Mar; 10():84. PubMed ID: 20211018
[TBL] [Abstract][Full Text] [Related]
7. γ-Tocotrienol reversal of epithelial-to-mesenchymal transition in human breast cancer cells is associated with inhibition of canonical Wnt signalling.
Ahmed RA; Alawin OA; Sylvester PW
Cell Prolif; 2016 Aug; 49(4):460-70. PubMed ID: 27323693
[TBL] [Abstract][Full Text] [Related]
8. Synergistic anticancer effects of combined γ-tocotrienol and oridonin treatment is associated with the induction of autophagy.
Tiwari RV; Parajuli P; Sylvester PW
Mol Cell Biochem; 2015 Oct; 408(1-2):123-37. PubMed ID: 26112904
[TBL] [Abstract][Full Text] [Related]
9. Suppression of cell proliferation and gene expression by combinatorial synergy of EGCG, resveratrol and gamma-tocotrienol in estrogen receptor-positive MCF-7 breast cancer cells.
Hsieh TC; Wu JM
Int J Oncol; 2008 Oct; 33(4):851-9. PubMed ID: 18813800
[TBL] [Abstract][Full Text] [Related]
10. Combined treatment of gamma-tocotrienol with statins induce mammary tumor cell cycle arrest in G1.
Wali VB; Bachawal SV; Sylvester PW
Exp Biol Med (Maywood); 2009 Jun; 234(6):639-50. PubMed ID: 19359655
[TBL] [Abstract][Full Text] [Related]
11. Tocotrienols promote apoptosis in human breast cancer cells by inducing poly(ADP-ribose) polymerase cleavage and inhibiting nuclear factor kappa-B activity.
Loganathan R; Selvaduray KR; Nesaretnam K; Radhakrishnan AK
Cell Prolif; 2013 Apr; 46(2):203-13. PubMed ID: 23510475
[TBL] [Abstract][Full Text] [Related]
12. γ-Tocotrienol-induced endoplasmic reticulum stress and autophagy act concurrently to promote breast cancer cell death.
Tiwari RV; Parajuli P; Sylvester PW
Biochem Cell Biol; 2015 Aug; 93(4):306-20. PubMed ID: 25844964
[TBL] [Abstract][Full Text] [Related]
13. Pro-apoptotic mechanisms of action of a novel vitamin E analog (alpha-TEA) and a naturally occurring form of vitamin E (delta-tocotrienol) in MDA-MB-435 human breast cancer cells.
Shun MC; Yu W; Gapor A; Parsons R; Atkinson J; Sanders BG; Kline K
Nutr Cancer; 2004; 48(1):95-105. PubMed ID: 15203383
[TBL] [Abstract][Full Text] [Related]
14. Tocotrienols target PI3K/Akt signaling in anti-breast cancer therapy.
Sylvester PW; Ayoub NM
Anticancer Agents Med Chem; 2013 Sep; 13(7):1039-47. PubMed ID: 23272909
[TBL] [Abstract][Full Text] [Related]
15. γ-Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: potential role as an antiproliferative, pro-apoptotic and chemosensitizing agent.
Rajendran P; Li F; Manu KA; Shanmugam MK; Loo SY; Kumar AP; Sethi G
Br J Pharmacol; 2011 May; 163(2):283-98. PubMed ID: 21198544
[TBL] [Abstract][Full Text] [Related]
16. Combined γ-tocotrienol and Met inhibitor treatment suppresses mammary cancer cell proliferation, epithelial-to-mesenchymal transition and migration.
Ayoub NM; Akl MR; Sylvester PW
Cell Prolif; 2013 Oct; 46(5):538-53. PubMed ID: 24033536
[TBL] [Abstract][Full Text] [Related]
17. gamma-Tocotrienol controls proliferation, modulates expression of cell cycle regulatory proteins and up-regulates quinone reductase NQO2 in MCF-7 breast cancer cells.
Hsieh TC; Elangovan S; Wu JM
Anticancer Res; 2010 Jul; 30(7):2869-74. PubMed ID: 20683025
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative effects of γ-tocotrienol are associated with lipid raft disruption in HER2-positive human breast cancer cells.
Alawin OA; Ahmed RA; Ibrahim BA; Briski KP; Sylvester PW
J Nutr Biochem; 2016 Jan; 27():266-77. PubMed ID: 26507543
[TBL] [Abstract][Full Text] [Related]
19. First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway.
Manu KA; Shanmugam MK; Ramachandran L; Li F; Fong CW; Kumar AP; Tan P; Sethi G
Clin Cancer Res; 2012 Apr; 18(8):2220-9. PubMed ID: 22351692
[TBL] [Abstract][Full Text] [Related]
20. The Vitamin E Derivative Gamma Tocotrienol Promotes Anti-Tumor Effects in Acute Myeloid Leukemia Cell Lines.
Ghanem P; Zouein A; Mohamad M; Hodroj MH; Haykal T; Abou Najem S; Naim HY; Rizk S
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31744219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
